NCT03459040: A reported trial by John Levine
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03459040 |
|---|---|
| Title | A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 17, 2018 |
| Completion date | Aug. 21, 2020 |
| Required reporting date | Aug. 21, 2021, midnight |
| Actual reporting date | April 29, 2021 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |